Allergy Skin Test Market Overview
The Allergy Skin Test Market is anticipated to reach USD 6.6 Billion by 2032 at 9.3% CAGR during the forecast period 2023-2032. Allergy is a condition caused by hypersensitivity of the immune system to various substance in the environment such as grass, pollen, dust, weeds and others. Some people develop allergic reactions on administration of drugs containing gluten. Allergic diseases include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis. Therefore, these allergic conditions are diagnosed by various types of tests such as allergy skin test. The test produces quick results for most for the allergens, thus determining the type of allergy so that the patients are recommended to avoid drugs or food stuffs containing the substance to which they are allergic. However, allergy skin tests may result in swollen red protrusions which may persist for a couple of days.
The market for allergy skin test is driven by an increasing prevalence of allergies such as rhinitis, asthma and allergic conjunctivitis, increasing number of patients with drug allergy, and growing demand of allergy testing across the globe. Furthermore, accurate and reliable results of allergy skin tests further boost the allergy skin test market growth.Â
Allergy Skin Test Market Segments  Â
The global allergy skin test market is segmented on the basis of type, indication, and end user.
On the basis of type, allergy skin test market is segmented into prick, intradermal, patch and others.
On the basis of indication, the allergy skin test market is segmented into allergy rhinitis, allergic asthma, drug allergy, allergic conjunctivitis, anaphylaxis, urticarial and others.
On the basis of end user, the allergy skin test market is segmented into hospitals & clinics, diagnostic centers, and others.
Global Allergy Skin Test Market Regional Analysis       Â
Europe is the largest market for allergy skin test. In Europe, the prevalence of allergic conditions is found to be increasing rapidly. Therefore, rising prevalence of allergic conditions such as food allergy, and anaphylaxis, increasing demand for diagnostic services and rising awareness and skin testing fuels the market growth. As per European Academy of Allergy and Clinical Immunology, 150 million EU citizens suffer from chronic allergic disease. Additionally, 100 million Europeans suffer from allergic rhinitis.
America holds the second position in the market for allergy skin test, owing to the rising prevalence of various types of allergies in the U.S. According to the American College of Allergy Asthma and Immunology, allergic asthma, food allergy, and eczema are the most common types of allergies found in the U.S. It further stated that one in every twelve people is suffering from allergic rhinitis in the U.S.
The allergy skin test market in Asia Pacific is expected to grow at the fastest pace and is driven by high prevalence of allergic asthma which is a direct consequence of the increasing environmental pollution, and rising geriatric population. Weakening immune system and prevalence of asthma are major reasons acting as risk factors for allergies in the elderly population.
The Middle East & Africa also show a steady rise in the market owing to high prevalence of chronic respiratory diseases like asthma, and improving healthcare infrastructure.
Key Players in the Global Allergy Skin Test Market Â
Some of the key players in allergy skin test market are Thermo Fischer Scientific (U.S.), Arlington Scientific, Inc. (U.S.), Cell Science Systems (U.S.), Quest Diagnostics Incorporated (U.S.), Lincoln Diagnostics, Inc. (U.S.), HollisterStier Allergy (U.S.), and Novartis Global (Switzerland).
Intended Audience
- Allergy Drug Manufacturers
- Allergy Drug Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Allergy Skin Test Market Highlights: